Procedure
Interval Debulking Surgery
Interval Debulking Surgery is a medical procedure with 5 clinical trials. Currently 3 active trials ongoing.
Total Trials
5
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
3(60%)
Phase Distribution
Ph phase_2
3
60%
Ph phase_3
2
40%
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Other(1)
Detailed Status
Recruiting2
Active, not recruiting1
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 23 (60.0%)
Phase 32 (40.0%)
Trials by Status
active_not_recruiting120%
unknown120%
not_yet_recruiting120%
recruiting240%
Recent Activity
3 active trials
Showing 5 of 5
not_yet_recruitingphase_2
Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
NCT07432594
recruitingphase_2
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07023484
recruitingphase_2
Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07022535
active_not_recruitingphase_3
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
NCT02859038
unknownphase_3
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
NCT03180177
Clinical Trials (5)
Showing 5 of 5 trials
NCT07432594Phase 2
Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
NCT07023484Phase 2
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07022535Phase 2
Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
NCT02859038Phase 3
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
NCT03180177Phase 3
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 5